Previous 10 | Next 10 |
Summary This is the first 2023 update on the long-term value portfolios consistently beating the S&P 500 since inception with S&P 500 +3.40%, DJIA -2.0% YTD. For 2023 the Piotroski-Graham value portfolio is up 15.0%, Negative Forensic Portfolio is up 11.5%, and Positive Fo...
NEW YORK, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that two studies on the remestemcel-L development program for the treatment of children with steroid-refractory acute gra...
NEW YORK, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that the United States Food and Drug Administration’s (FDA) Office of Tissues and Advanced Therapies (OTAT) has gr...
Validation of Remestemcel-L Potency Assay used in the Phase 3 Trial which Measures In-Vivo Activity based on Mechanism of Action Assay Identifies High-Potency Product Lots Associated with Enhanced Survival New Data Show that Remestemcel-L Improves Inflammatory Biomarkers and Sur...
NEW YORK, Jan. 31, 2023 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided an activity report for the second quarter ended December 31, 2022. Financial Highlights Revenue from royal...
Summary Mesabi Trust has been a great investment for decades with steady price appreciation and a high rate of dividends. The temporary closure of its main resource asset by a mining unit of Cleveland-Cliffs has halted nearly all royalty revenue. Few net assets exist to back up Mesa...
Mesabi Trust ( NYSE: MSB ) on Thursday said its trustees have determined that no distribution will be declared in January 2023 with respect to units of beneficial interest. The trustees said the announcement reflects caution about uncertainties arising from the July 22, 2022 annou...
Summary Mesabi Trust is a yield vehicle that has recently paused its yield. The operator of the Northshore facility has shut it down temporarily. As long as the operator doesn't restart the mine, there are unlikely to be any payouts. Long-term payouts should be highly attr...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips My task today is to find seven of the most undervalued long-term stocks to buy now. We need to determine two things before stock selection takes place. First, it’s important to define what is meant by long-term. Se...
Mesabi Trust ( NYSE: MSB ) -8.1% post-market Friday after the trustees said no distribution will be declared this month , reflecting uncertainties caused by Cleveland-Cliffs' ( CLF ) announcement in July to extend the idling of operations at Northshore Mining until a...
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, July 23, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, announced that the United States Food and Drug Administration (FDA) has accepted its Biologics License Application (BLA) resubmission for...
NEW YORK, July 21, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, announced today that the confirmatory Phase 3 trial of its allogeneic, immunoselected, and industrially manufactured stromal cell product...
2024-07-13 04:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...